Inventor · disambiguated record
Jag Paul Heer
Also filed as: HEER JAG P · HEER JAG PAUL
27 granted patents·16 pending applications·60 citations·filing 1999–2020
94Inventor score
Files withUCB Biopharma SRL14HEER JAG PAUL8UCB BIOPHARMA SPRL8BESWICK PAUL JOHN3SMITHKLINE BEECHAM PLC2
Top patents by PatentIndex Score
43 records- 0189US9969728B2Tetrahydroimidazopyridine derivatives as modulators of TNF activityUCB BIOPHARMA SPRL·Filed 2014·Granted May 15, 2018·14 cites·7 claims
- 0285US10906919B2Fused pentacyclic imidazole derivativesUCB Biopharma SRL·Filed 2018·Granted Feb 2, 2021·2 cites·10 claims
- 0384US10087179B2Fused tricyclic imidazole derivatives as modulators of TNF activityUCB BIOPHARMA SPRL·Filed 2014·Granted Oct 2, 2018·8 cites·11 claims
- 0484US9932343B2Fused tricyclic benzimidazoles derivatives as modulators of TNF activityUCB BIOPHARMA SPRL·Filed 2014·Granted Apr 3, 2018·10 cites·16 claims
- 0583US9890174B2Fused Tricyclic imidazole derivatives as modulators of TNF activityUCB BIOPHARMA SPRL·Filed 2014·Granted Feb 13, 2018·8 cites·16 claims
- 0682US10202405B2Fused pentacyclic imidazole derivativesUCB BIOPHARMA SPRL·Filed 2015·Granted Feb 12, 2019·4 cites·11 claims
- 0777US8288388B23-pyridylcarbonyl-piperazinylsulfonyl derivativesBESWICK PAUL JOHN·Filed 2009·Granted Oct 16, 2012·4 cites·27 claims
- 0874US9926313B2Imidazopyridine derivatives as modulators of TNF activityUCB BIOPHARMA SPRL·Filed 2014·Granted Mar 27, 2018·2 cites·8 claims
- 0972US8222245B2Oxadiazole derivatives active on sphingosine-1-phosphate (S1P)DEMONT EMMANUEL HUBERT·Filed 2008·Granted Jul 17, 2012·1 cites·5 claims
- 1071US8278324B2Oxadiazole derivatives active on sphingosine-1-phosphate (S1P)HEER JAG PAUL·Filed 2008·Granted Oct 2, 2012·1 cites·3 claims
- 1169US10472362B2Fused tricyclic imidazo pyrazines as modulators of TNF activityUCB BIOPHARMA SPRL·Filed 2016·Granted Nov 12, 2019·1 cites·11 claims
- 1269US10093652B2Tetrahydrobenzimidazole derivatives as modulators of TNF activityUCB BIOPHARMA SPRL·Filed 2014·Granted Oct 9, 2018·1 cites·5 claims
- 1367US11912721B2Fused pentacyclic imidazole derivativesUCB Biopharma SRL·Filed 2020·Granted Feb 27, 2024·0 cites·16 claims
- 1462US8530478B2Piperazine derivatives used as CAV2.2 calcium channel modulatorsBESWICK PAUL JOHN·Filed 2009·Granted Sep 10, 2013·0 cites·25 claims
- 1558US2010174065A1CompoundsGLAXO GROUP LTD·Filed 2009·Application pending·0 cites
- 1653US8536183B23-pyridylcarbonyl-piperazinylsulfonyl derivativesBESWICK PAUL JOHN·Filed 2012·Granted Sep 17, 2013·0 cites·1 claims
- 1751US8263620B2Oxadiazole derivatives active on sphingosine-1-phosphate (SIP)HEER JAG PAUL·Filed 2008·Granted Sep 11, 2012·0 cites·4 claims
- 1851US8093249B2Pyrazolo[1,5-A]pyrimidine-carbonyl-piperazine derivativesHEER JAG PAUL·Filed 2009·Granted Jan 10, 2012·0 cites·23 claims
- 1950US10669263B2Substituted benzimidazole derivative as a modulator of TNF activityUCB Biopharma SRL·Filed 2017·Granted Jun 2, 2020·0 cites·5 claims
- 2050US2004220230A1PyridinylimidazolesSMITHKLINE BEECHAM PLC·Filed 2004·Application pending·0 cites
- 2149US12410161B2Tetrahydrobenzo-quinoline sulfonamides derivative compoundsUCB Biopharma SRL·Filed 2020·Granted Sep 9, 2025·0 cites·18 claims
- 2248US2010261767A1Oxadiazole derivatives for use as s1p1 agonists in the treatment of autoimmune and inflammatory disordersHEER JAG PAUL·Filed 2008·Application pending·0 cites
- 2348US2023192646A1Dihydro-cyclopenta-isoquinoline derivativesUCB Biopharma SRL·Filed 2020·Application pending·0 cites
- 2448US2010273770A11, 2, 4 -oxadiazole compounds for the treatment of autoimmune diseasesHEER JAG PAUL·Filed 2008·Application pending·0 cites
- 2547US2010227870A1Novel CompoundsGIANOTTI MASSIMO·Filed 2008·Application pending·0 cites
- 2646US2024092773A1Dihydro-cyclopenta-isoquinoline sulfonamides derivativesUCB Biopharma SRL·Filed 2020·Application pending·0 cites
- 2745US8329730B2CompoundsHEIGHTMAN THOMAS DANIEL·Filed 2009·Granted Dec 11, 2012·0 cites·4 claims
- 2845US2022073485A1Functionalised Amine Derivatives as IL-17 ModulatorsUCB Biopharma SRL·Filed 2019·Application pending·0 cites
- 2944US2007191378A1Anthranilic acid derivatives and their use as activators of the hm74a receptorSMITHKLINE BEECHAM CORP·Filed 2004·Application pending·0 cites
- 3043US10953019B2Fused pentacyclic imidazole derivatives as modulators of TNF activityUCB Biopharma SRL·Filed 2018·Granted Mar 23, 2021·0 cites·12 claims
- 3143US2023050670A1Tetrahydrobenzo-quinoline sulfonamide derivatives useful as ige modulatorsUCB Biopharma SRL·Filed 2020·Application pending·0 cites
- 3242US10766906B2Fused hexacyclic imidazole derivatives as modulators of TNF activityUCB Biopharma SRL·Filed 2017·Granted Sep 8, 2020·0 cites·5 claims
- 3341US6492378B1Substituted isoquinoline derivatives and their use as anticonvulsivantsSMITHKLINE BEECHAM PLC·Filed 1999·Granted Dec 10, 2002·4 cites·8 claims
- 3441US2010099690A1Xanthine derivatives as selective hm74a agonistsHEER JAG PAUL·Filed 2006·Application pending·0 cites
- 3541US2004266842A1Thiazolyl substituted triazoles as alk5 inhibitorsGASTER LARAMIE MARY·Filed 2002·Application pending·0 cites
- 3641US2005014938A1Phenyl substituted triazoles and their use as selective inhibitors of akl5 kinaseFiled 2002·Application pending·0 cites
- 3741US2010152235A1Oxadiazole derivatives active on sphingosine-1-phosphate (s1p)HEER JAG PAUL·Filed 2010·Application pending·0 cites
- 3840US10669286B2Fused pentacyclic imidazole derivatives as modulators of TNF activityUCB Biopharma SRL·Filed 2017·Granted Jun 2, 2020·0 cites·10 claims
- 3939US2004152738A1Pyridyl-substituted triazoles as tgf inhibitorsFiled 2001·Application pending·0 cites
- 4038US10793578B2Fused pentacyclic imidazole derivatives as modulators of TNF activityUCB Biopharma SRL·Filed 2017·Granted Oct 6, 2020·0 cites·7 claims
- 4138US10654861B2Fused pentacyclic imidazole derivatives as modulators of TNF activityUCB Biopharma SRL·Filed 2017·Granted May 19, 2020·0 cites·9 claims
- 4237US8697703B2Piperazine derivatives for blocking Cav2.2 calcium channelsHEER JAG PAUL·Filed 2011·Granted Apr 15, 2014·0 cites·12 claims
- 4336US2020399268A1Pharmaceutical 6,5 Heterobicyclic Ring DerivativesUCB Biopharma SRL·Filed 2019·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Jag Paul Heer files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →